Suppr超能文献

2022年HIV的晚期诊断情况:为何变化如此之小?

Late diagnosis of HIV in 2022: Why so little change?

作者信息

Collins Simon, Namiba Angelina, Sparrowhawk Alex, Strachan Sophie, Thompson Marc, Nakamura Hideta

机构信息

HIV i-Base, London, UK.

4M Network of Mentor Mothers, London, UK.

出版信息

HIV Med. 2022 Dec;23(11):1118-1126. doi: 10.1111/hiv.13444. Epub 2022 Nov 17.

Abstract

BACKGROUND

The proportion of people who are diagnosed late is a key metric to measure the public health response to HIV. But this percentage remains stubbornly high in nearly every country. Delays in accessing antiretroviral therapy affects both (i) individual health, due to a higher risk of mortality, and (ii) population-based health, due to continued risk of transmission. Despite huge efforts to increase testing, late diagnosis continues to be an indication of a public health failure.

OUTLINE

This short review includes community perspectives on why late diagnosis continues and how it may be reduced. We discuss both structural barriers that prevent people from testing earlier and personal reasons why some people still refuse testing when offered. We note that late diagnosis is reported in all countries and in all demographic groups and that sex, gender, age, and sexuality all affect these rates. However, even in groups with high HIV awareness, such as in gay and bisexual men in the UK, more than one in three people with HIV continue to be diagnosed late. Fears and prejudice about HIV based on outdated information are still common among both health workers and people using health services. For example, testing is still not offered in primary or emergency care settings, and even free testing might not be accepted if someone fears the outcome might jeopardize their resident status, employment, relationship, or health.

SUMMARY

In addition to developing targeted projects to reach the highest-risk groups, a positive mainstream public campaign could make testing more acceptable at a broad population level across all demographics. This could challenge and repair the media campaigns from the 1980s that still contribute to the stigma that frightens people away from testing now. We hope that an effective approach in one country might also help others.

摘要

背景

晚期诊断的人群比例是衡量公众对艾滋病毒应对措施的关键指标。但几乎在每个国家,这一比例都居高不下。延迟获得抗逆转录病毒疗法会对以下两方面产生影响:(i)个人健康,因为死亡风险更高;(ii)基于人群的健康,因为存在持续传播风险。尽管在增加检测方面付出了巨大努力,但晚期诊断仍然表明公共卫生工作存在失败之处。

概述

本简短综述纳入了社区对于晚期诊断持续存在的原因以及如何减少晚期诊断的观点。我们讨论了阻碍人们更早进行检测的结构性障碍,以及一些人在获得检测机会时仍拒绝检测的个人原因。我们注意到,所有国家和所有人口群体中都存在晚期诊断情况,性别、年龄和性取向都会影响这些比率。然而,即使在艾滋病毒知晓率较高的群体中,比如英国的男同性恋者和双性恋男性,三分之一以上的艾滋病毒感染者仍被诊断为晚期。基于过时信息对艾滋病毒的恐惧和偏见在医护人员和使用医疗服务的人群中仍然很常见。例如,初级或急诊护理环境中仍不提供检测,而且如果有人担心检测结果可能危及他们的居民身份、就业、人际关系或健康,即使是免费检测也可能不被接受。

总结

除了开展针对高危群体的项目外,积极的主流公众宣传活动可以使检测在所有人口群体的广泛层面上更容易被接受。这可以挑战并修复20世纪80年代的媒体宣传活动,这些活动至今仍造成污名化,使人们不敢进行检测。我们希望一个国家的有效方法也能帮助其他国家。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验